Pacific Biosciences of California PACB Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's accrued liabilities, current?
- Pacific Biosciences of California (PACB) reported accrued liabilities, current of $33.9M in Q1 2026.
- How has Pacific Biosciences of California's accrued liabilities, current changed year-over-year?
- Pacific Biosciences of California's accrued liabilities, current increased by 15.6% year-over-year, from $29.34M to $33.9M.
- What is the long-term trend for Pacific Biosciences of California's accrued liabilities, current?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's accrued liabilities, current has grown at a 14.2% compound annual growth rate (CAGR), from $17.35M to $33.65M.